Cochrane Airways publishes Cochrane Evidence on the effects of treatments in the management of obstructive or inflammatory diseases of the airway. Our reviews cover the following topics:
- Chronic and acute asthma (including allergic / atopic asthma, exercise-induced asthma, and occupational asthma)
- Stable and acute chronic obstructive pulmonary disease (chronic bronchitis/emphysema)
- Obstructive sleep apnoea
- Bronchiectasis
- Interstitial lung disease, idiopathic pulmonary fibrosis and pulmonary sarcoidosis
- Pulmonary hypertension
- Chronic and sub-acute cough (cough lasting over 3 weeks)
The following related topics are covered by other Cochrane groups as indicated below:
- Rhinitis (Cochrane ENT)
- Lung cancer (Cochrane Lung Cancer)
- Acute bronchitis, bronchiolitis, pneumonia and emphysema (Cochrane ARI
- Anaphylaxis and acute respiratory distress syndrome (Cochrane ACE)
- Cystic fibrosis (Cochrane Cystic Fibrosis and Genetic Disorders)
- Interventions to prevent and treat tobacco addiction (Cochrane Tobacco Addiction)